Form 10-Q · Quarterly report
Fair Isaac 10-Q, filed Jul 29, 2026
- Filed
- CIK
- 0000814547
- Accession no.
- 0000814547-26-000030
Summary
Fair Isaac reported total revenues of $674.2 million for the quarter ended June 30, 2026, up 26% from a year earlier, with net income of $237.2 million (up 30%) and diluted EPS of $10.45 (up 41%). In June 2026 the company amended its credit agreement for a $1.5 billion term loan to fund an accelerated share repurchase, lifting total debt to $5.6 billion from $3.1 billion at September 30, 2025.
Key points
- Scores segment revenues were $458.9 million for the quarter, up 41% year over year, and $1.2 billion for the nine months, up 45%.
- Software segment annual recurring revenue was $815.8 million as of June 30, 2026, up 10% year over year, with a dollar-based net retention rate of 109%.
- Operating income was $362.6 million for the quarter, up 38%, and cash flows from operating activities were $777.9 million for the nine months.
- Share repurchases were $2.3 billion in the quarter and $3.1 billion for the nine months, including $1.5 billion paid under the accelerated share repurchase agreement.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management’s Discussion OVERVIEW We were founded in 1956 on the premise that data, used intelligently, can improve business decisions. Today, FICO’s software and the widely used FICO® Score operationalize analytics, enabling thousands of businesses in more than 80 countries to uncover new opportunities, make timely decisions that matter, and execute them at scale. Most leading banks and credit card issuers rely on our solutions, as do insurers, retailers, telecommunications providers, automotive lenders, consumer reporting agencies, public agencies, and organizations in other industries. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.